The Role of E3 Ligase Pirh2 in Disease

Cells. 2022 Apr 30;11(9):1515. doi: 10.3390/cells11091515.

Abstract

The p53-dependent ubiquitin ligase Pirh2 regulates a number of proteins involved in different cancer-associated processes. Targeting the p53 family proteins, Chk2, p27Kip1, Twist1 and others, Pirh2 participates in such cellular processes as proliferation, cell cycle regulation, apoptosis and cellular migration. Thus, it is not surprising that Pirh2 takes part in the initiation and progression of different diseases and pathologies including but not limited to cancer. In this review, we aimed to summarize the available data on Pirh2 regulation, its protein targets and its role in various diseases and pathological processes, thus making the Pirh2 protein a promising therapeutic target.

Keywords: E3 ligase; HIV-1; Pirh2; RCHY1; SARS-CoV; cancer; nerve injury; p53 protein family; ubiquitination; virus infection.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Cycle Checkpoints
  • Tumor Suppressor Protein p53* / metabolism
  • Ubiquitin / metabolism
  • Ubiquitin-Protein Ligases* / metabolism
  • Ubiquitination

Substances

  • Tumor Suppressor Protein p53
  • Ubiquitin
  • Ubiquitin-Protein Ligases

Grants and funding

This research was funded by RUSSIAN SCIENCE FOUNDATION (RSF), # 18-75-10076.